vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与Rumble Inc.（RUM）财务数据对比。点击上方公司名可切换其他公司
Rumble Inc.的季度营收约是CUMBERLAND PHARMACEUTICALS INC的2.0倍（$27.1M vs $13.7M），CUMBERLAND PHARMACEUTICALS INC净利率更高（-10.3% vs -120.8%，领先110.5%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs -10.5%），CUMBERLAND PHARMACEUTICALS INC自由现金流更多（$3.0K vs $-31.7M），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 15.2%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
Rumble Inc.是一家加美跨国企业，主营在线视频平台、网络托管及云服务，总部位于加拿大多伦多，美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立，云服务板块为Truth Social提供托管支持，其视频平台在美国保守派及极右翼用户群体中广受欢迎，属于“另类科技”阵营。
CPIX vs RUM — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $27.1M |
| 净利润 | $-1.4M | $-32.7M |
| 毛利率 | 83.6% | 5.5% |
| 营业利润率 | -10.0% | -131.1% |
| 净利率 | -10.3% | -120.8% |
| 营收同比 | 31.1% | -10.5% |
| 净利润同比 | 25.8% | 86.2% |
| 每股收益（稀释后） | $-0.09 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $13.7M | $27.1M | ||
| Q3 25 | $8.3M | $24.8M | ||
| Q2 25 | $10.8M | — | ||
| Q1 25 | $11.7M | $23.7M | ||
| Q4 24 | $10.4M | $30.2M | ||
| Q3 24 | $9.1M | $25.1M | ||
| Q2 24 | $9.8M | $22.5M | ||
| Q1 24 | $8.5M | $17.7M |
| Q4 25 | $-1.4M | $-32.7M | ||
| Q3 25 | $-1.9M | $-16.3M | ||
| Q2 25 | $-740.7K | — | ||
| Q1 25 | $1.3M | $-2.7M | ||
| Q4 24 | $-1.9M | $-236.8M | ||
| Q3 24 | $-1.5M | $-31.5M | ||
| Q2 24 | $-1.1M | $-26.8M | ||
| Q1 24 | $-1.9M | $-43.3M |
| Q4 25 | 83.6% | 5.5% | ||
| Q3 25 | 88.1% | -1.8% | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | -26.7% | ||
| Q4 24 | 81.1% | -14.2% | ||
| Q3 24 | 85.4% | -45.4% | ||
| Q2 24 | 82.6% | -58.8% | ||
| Q1 24 | 81.5% | -79.5% |
| Q4 25 | -10.0% | -131.1% | ||
| Q3 25 | -23.7% | -113.6% | ||
| Q2 25 | -6.9% | — | ||
| Q1 25 | 11.0% | -153.5% | ||
| Q4 24 | -17.7% | -80.1% | ||
| Q3 24 | -18.6% | -131.0% | ||
| Q2 24 | -10.4% | -172.7% | ||
| Q1 24 | -22.0% | -197.4% |
| Q4 25 | -10.3% | -120.8% | ||
| Q3 25 | -23.4% | -65.7% | ||
| Q2 25 | -6.8% | — | ||
| Q1 25 | 10.7% | -11.2% | ||
| Q4 24 | -18.2% | -783.2% | ||
| Q3 24 | -17.0% | -125.9% | ||
| Q2 24 | -11.0% | -119.2% | ||
| Q1 24 | -22.9% | -244.1% |
| Q4 25 | $-0.09 | $-0.13 | ||
| Q3 25 | $-0.13 | $-0.06 | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | $0.08 | $-0.01 | ||
| Q4 24 | $-0.13 | $-1.17 | ||
| Q3 24 | $-0.11 | $-0.15 | ||
| Q2 24 | $-0.08 | $-0.13 | ||
| Q1 24 | $-0.14 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $237.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $24.9M | $274.8M |
| 总资产 | $76.8M | $336.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $11.4M | $237.9M | ||
| Q3 25 | $15.2M | $269.8M | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $15.1M | $301.3M | ||
| Q4 24 | $18.0M | $114.0M | ||
| Q3 24 | $17.5M | $132.0M | ||
| Q2 24 | $17.3M | $154.2M | ||
| Q1 24 | $18.5M | $183.8M |
| Q4 25 | $24.9M | $274.8M | ||
| Q3 25 | $26.1M | $302.2M | ||
| Q2 25 | $28.0M | — | ||
| Q1 25 | $28.7M | $339.6M | ||
| Q4 24 | $22.9M | $-63.1M | ||
| Q3 24 | $24.8M | $166.1M | ||
| Q2 24 | $26.3M | $192.7M | ||
| Q1 24 | $27.5M | $210.7M |
| Q4 25 | $76.8M | $336.8M | ||
| Q3 25 | $65.9M | $367.2M | ||
| Q2 25 | $67.9M | — | ||
| Q1 25 | $69.9M | $391.1M | ||
| Q4 24 | $75.6M | $195.3M | ||
| Q3 24 | $76.7M | $217.2M | ||
| Q2 24 | $78.5M | $243.2M | ||
| Q1 24 | $81.5M | $263.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $-29.4M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $-31.7M |
| 自由现金流率自由现金流/营收 | 0.0% | -117.2% |
| 资本支出强度资本支出/营收 | 0.0% | 8.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.8M | $-70.8M |
8季度趋势，按日历期对齐
| Q4 25 | $3.0K | $-29.4M | ||
| Q3 25 | $187.2K | $-10.6M | ||
| Q2 25 | $843.8K | — | ||
| Q1 25 | $3.9M | $-14.5M | ||
| Q4 24 | $1.9M | $-12.4M | ||
| Q3 24 | $475.5K | $-19.1M | ||
| Q2 24 | $-855.7K | $-21.7M | ||
| Q1 24 | $-2.1M | $-33.9M |
| Q4 25 | $3.0K | $-31.7M | ||
| Q3 25 | $163.4K | $-12.0M | ||
| Q2 25 | $817.3K | — | ||
| Q1 25 | $3.9M | $-14.6M | ||
| Q4 24 | $1.9M | $-12.4M | ||
| Q3 24 | $460.1K | $-19.9M | ||
| Q2 24 | $-862.8K | $-23.1M | ||
| Q1 24 | $-2.2M | $-34.3M |
| Q4 25 | 0.0% | -117.2% | ||
| Q3 25 | 2.0% | -48.6% | ||
| Q2 25 | 7.5% | — | ||
| Q1 25 | 32.9% | -61.7% | ||
| Q4 24 | 18.2% | -40.9% | ||
| Q3 24 | 5.1% | -79.5% | ||
| Q2 24 | -8.8% | -102.8% | ||
| Q1 24 | -25.6% | -193.3% |
| Q4 25 | 0.0% | 8.5% | ||
| Q3 25 | 0.3% | 5.7% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.2% | 3.4% | ||
| Q2 24 | 0.1% | 6.1% | ||
| Q1 24 | 0.5% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPIX
暂无分部数据
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
